Note: this posting has been revised from the previous version. An analysis developed with the aid of the USAID-funded Deliver Project shows that Zambia is facing a massive gap in the financing required to reach country targets for expanded access to antiretroviral therapy (ART). The gap goes from $8.2 million for 2011 to a whopping […]
Here are some quick summaries of technological newsmakers from the past week: Two cancer drugs stop HIV in its tracks: Using a mixture of two anti-cancer drugs already on the market, researchers at the University of Minnesota say they have found a promising new treatment for HIV. During lab experiments with mice,” the drugs gemcitabine and […]
HIV
The goals of controlling HIV sound like a straight forward series of three consecutive steps, one following another, when discussed in global and domestic epidemic-ending plans. […]
Tuberculosis
The announcement Wednesday of U.S. Food and Drug Administration approval of pretomanid, a new tuberculosis drug that has been part of a ground-breaking treatment regimen against […]
Research & Development
A randomized, multi-country clinical trial testing a regimen for treating drug-resistant tuberculosis in less than a year against the up to two-year regimen recommended by the […]
Policy
The Ebola Virus is Winning – This comprehensive analysis by J. Stephen Morrison of the Center for Strategic & International Studies explains how with unprecedented advantages […]